MONDAY, March 3, 2025 -- More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an...
Vous n'êtes pas connecté
Monday, March 3, 2025 -- A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than oral immunotherapy (OIT) in people with allergic reactions to very small amounts of common food...
MONDAY, March 3, 2025 -- More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an...
MONDAY, March 3, 2025 -- Omalizumab is superior to oral immunotherapy (OIT) for multifood allergy, and most patients include dietary consumption (DC)...
March 07, 2025 -- Today, the U.S. Food and Drug Administration approved as the first interchangeable biosimilar to Xolair (omalizumab). Omlyclo, like...
South San Francisco, CA -- March 2, 2025 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new positive data...
SAN DIEGO, March 05, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk...
WEDNESDAY, March 5, 2025 -- The U.S. Food and Drug Administration has expanded its indication of Odactra, a house dust mite allergen tablet, for the...
SGLT2 inhibitors, a diabetes medication, may protect the heart and reduce hospitalizations for cancer patients, particularly those treated with...
A trial at English secondary schools of alternative food labeling - which displayed the number of minutes of physical activity needed to burn off...
An expanded clinical trial that tested a groundbreaking, experimental stem cell treatment for blinding cornea injuries found the treatment was...
A new study has found that a form of vitamin E, called α-tocopherol, may help reduce food allergies and severe allergic reactions in newborns when...